View More Recent Stories
-
Piper Sandler Reiterates Overweight Rating on Illumina (ILMN)
-
These stocks offer you exposure to rising demand for fertility treatment – Barclays
-
Life Science Tools & Diagnostics stocks: Q2 earnings preview
-
TD Cowen Reiterates Hold Rating on 10X Genomics (TXG)
-
10x Genomics (TXG) Declines After Illumina (ILMN) Acquires Fluent BioSciences
-
Illumina (ILMN) acquires Fluent BioSciences
-
Illumina (ILMN) call put ratio 1 call to 9.1 puts with focus on August 90 puts with stocks price at $107.42
-
Increasing unusual put option volume: BKR PTEN NWL TPX GLW CMG FITB ILMN SMR CC
-
Illumina (ILMN) PT Lowered to $131 at UBS
-
Illumina (ILMN) PT Lowered to $119 at Baird
-
GRAIL (GRAL) to Commence Separate Trading on Nasdaq
-
Illumina (ILMN) completes divestiture of GRAIL
-
Illumina (ILMN) Launches DRAGEN v4.3
-
Illumina (ILMN) PT Lowered to $175 at Evercore ISI
-
Midday movers: Southwest Airlines, CrowdStrike, KKR rise; AMD falls
-
CrowdSrike, KKR, and GoDaddy shares rise after S&P 500 inclusion news

